Main > A1. CORP. INDEX. En-Ez > Eton Pharmaceuticals Inc./P C2



Eton Pharmaceuticals Inc./P C2's subsections
2019. 10.22. U.S. FDA Approval
2019. 12.02. U.S. Launch
2020. 01.21. CoPromotion
2020. 03.27. Endo.>AI>USA Rights AC
2020. 09.29. Endo.>AI>USA>OK
2020. 11.24. Endo.>AI>USA>Launch
2021. 01.14. Endo.>AI>CA Rights AC
2021. 02.08. Sale Neuro. Portfolio
2021. 06.15. USA FDA Approval
2022. 03.14. USA Launch
2023. 03.15. Acq. ET-600 from
2024. 02.02. USA Launch
2024. 02.21. USA Patent
web-site

Eton Pharmaceuticals Inc./P C2's products
This section has no products